Applications

Full‑scale life simulation opens new ground.

Four scenarios share one foundation: data interfaces into a unified representation, patient-state models, simulation modules for plan comparison and risk boundaries, and validation protocols that make every project a reusable operator asset.

For pharma — clinical development, translational medicine, biostatistics

Drug R&D

Clinical-trial design
Indication and population selection
Efficacy probability and extrapolation boundaries
In-silico drug testing

For innovative device companies and clinical teams

Device R&D

Structure–function–intervention coupled simulation
Plan comparison and virtual validation
Risk-boundary definition

For hospital departments, physician teams, MDT

Treatment decisions

Patient-state reconstruction
Intervention-plan comparison
Efficacy and recurrence risk, MDT support
Disease-course simulation

For screening centers, health managers, insurers, employers

Health management

Risk trajectories and re-examination cadence
Intervention advice and long-term tracking
Natural-aging simulation

01 — Project-based validation, with clear deliverables02 — Operator assets that accumulate and get reused03 — Licensed disease models and platform services

Case studies

Delivered, in the real R&D pipeline.

Gyn-World

Virtual clinical trials for gynecologic oncology drugs

A unified patient-state model: longitudinal EHR and multimodal inputs → a shared, continuously updated state space → task outputs across ovarian, cervical and endometrial cancers.

Pre-trial

Indication and cohort feasibility
Eligibility optimization, virtual patients
Design, endpoints, sample-size scenarios

Within-trial

Patient matching and dynamic stratification
Efficacy and safety signal monitoring
Structured EHR extraction

Post-trial

Generalization to target populations
Benefit groups and extrapolation boundaries
Digital twins for extension studies

Client value: find the right patients faster, optimize trial design earlier, and judge whether results extrapolate.

Cardio virtual trial

Cardiovascular device virtual clinical trial

Transcatheter hydrogel injection for chronic heart failure: the space of injection sites, doses and material parameters is too large to explore in early human trials. Simulation narrows it — and delivers executable comparisons.

01 · Virtual patients

Comparable cohorts formed by structure, function and pathology.

02 · Reconstruction

Patient-specific cardiac geometry, mechanics and functional state.

03 · Multi-scale simulation

Local tissue response through organ-level functional change, per plan.

04 · Comparison & boundaries

Plan ranking, parameter sensitivity maps, risk windows, traceable reports.

Delivered. The corresponding product has since advanced to Phase II clinical trials.

Gut-World

Digestive-tract health simulation

From an individual’s real endoscopy, pathology and history: current state → future evolution → post-intervention trajectory. A continuously updated personal digestive-state model, not a one-off report.

Current state

Gut health score, gut age, key risk factors.

Future trajectory

Polyp and risk evolution over coming years, with uncertainty bands.

Scenario comparison

Re-examination cadence, lifestyle and diet — simulated side by side.

Continuous update

New data revises the state, with explained changes.

A product entry in premium screening and health management — paving the road to disease-specific screening and early diagnosis services.

Bring a decision worth simulating.

Start a conversation